U.S. Markets closed
  • S&P 500

    3,818.83
    -2.72 (-0.07%)
     
  • Dow 30

    31,029.31
    +82.32 (+0.27%)
     
  • Nasdaq

    11,177.89
    -3.65 (-0.03%)
     
  • Russell 2000

    1,719.37
    -19.47 (-1.12%)
     
  • Crude Oil

    109.70
    -0.08 (-0.07%)
     
  • Gold

    1,820.00
    +2.50 (+0.14%)
     
  • Silver

    20.72
    -0.02 (-0.09%)
     
  • EUR/USD

    1.0449
    +0.0005 (+0.0522%)
     
  • 10-Yr Bond

    3.0930
    -0.1130 (-3.52%)
     
  • Vix

    28.16
    -0.20 (-0.71%)
     
  • GBP/USD

    1.2129
    +0.0007 (+0.0582%)
     
  • USD/JPY

    136.5310
    -0.0140 (-0.0102%)
     
  • BTC-USD

    20,097.77
    -186.98 (-0.92%)
     
  • CMC Crypto 200

    434.46
    -5.20 (-1.18%)
     
  • FTSE 100

    7,312.32
    -11.09 (-0.15%)
     
  • Nikkei 225

    26,804.60
    -244.87 (-0.91%)
     

Teladoc (TDOC) Gains But Lags Market: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In the latest trading session, Teladoc (TDOC) closed at $34.61, marking a +0.23% move from the previous day. This move lagged the S&P 500's daily gain of 0.31%. Meanwhile, the Dow gained 0.05%, and the Nasdaq, a tech-heavy index, added 0.14%.

Heading into today, shares of the telehealth services provider had gained 3.23% over the past month, outpacing the Medical sector's loss of 0.97% and the S&P 500's loss of 1.38% in that time.

Wall Street will be looking for positivity from Teladoc as it approaches its next earnings report date. The company is expected to report EPS of -$0.71, up 17.44% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $586.79 million, up 16.62% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$43.18 per share and revenue of $2.42 billion, which would represent changes of -3146.62% and +19.1%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for Teladoc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.17% lower. Teladoc is holding a Zacks Rank of #3 (Hold) right now.

The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 167, putting it in the bottom 34% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.